Pooled Analysis of Studies Evaluating Fosnetupitant and Risk Factors for Cisplatin-Induced Nausea and Vomiting During the Extended Overall Phase

INTRODUCTION: Fosnetupitant is a novel neurokinin 1 receptor antagonist (NK(1)RA) with favorable antiemetic efficacy in patients receiving emetogenic chemotherapy. This study assessed the efficacy of fosnetupitant in combination with palonosetron and dexamethasone and identified risk factors for che...

Descripción completa

Detalles Bibliográficos
Autores principales: Inui, Naoki, Toi, Yukihiro, Yoneshima, Yasuto, Morise, Masahiro, Hata, Akito, Kubota, Kaoru, Saeki, Toshiaki, Tamura, Tomohide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567891/
https://www.ncbi.nlm.nih.gov/pubmed/37715851
http://dx.doi.org/10.1007/s12325-023-02648-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567891/
https://www.ncbi.nlm.nih.gov/pubmed/37715851
http://dx.doi.org/10.1007/s12325-023-02648-1

Ejemplares similares